AU2828795A - Monoclonal antibodies for the reduction of anti-xenogeneic immune responses - Google Patents

Monoclonal antibodies for the reduction of anti-xenogeneic immune responses

Info

Publication number
AU2828795A
AU2828795A AU28287/95A AU2828795A AU2828795A AU 2828795 A AU2828795 A AU 2828795A AU 28287/95 A AU28287/95 A AU 28287/95A AU 2828795 A AU2828795 A AU 2828795A AU 2828795 A AU2828795 A AU 2828795A
Authority
AU
Australia
Prior art keywords
reduction
monoclonal antibodies
immune responses
xenogeneic immune
xenogeneic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28287/95A
Inventor
Louis A Matis
Eileen Elliott Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of AU2828795A publication Critical patent/AU2828795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU28287/95A 1994-06-17 1995-06-14 Monoclonal antibodies for the reduction of anti-xenogeneic immune responses Abandoned AU2828795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26148394A 1994-06-17 1994-06-17
US261483 1994-06-17
PCT/US1995/007556 WO1995035120A1 (en) 1994-06-17 1995-06-14 Monoclonal antibodies for the reduction of anti-xenogeneic immune responses

Publications (1)

Publication Number Publication Date
AU2828795A true AU2828795A (en) 1996-01-15

Family

ID=22993501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28287/95A Abandoned AU2828795A (en) 1994-06-17 1995-06-14 Monoclonal antibodies for the reduction of anti-xenogeneic immune responses

Country Status (2)

Country Link
AU (1) AU2828795A (en)
WO (1) WO1995035120A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs

Also Published As

Publication number Publication date
WO1995035120A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
AU3811495A (en) Antibodies
EP0692536A3 (en) IFN-Y production inducing protein and monoclonal antibody of the same
PT837927E (en) Anti-cd80 antibodies
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU1704099A (en) Monoclonal human natural antibodies
AU4618193A (en) Humanized antibodies
AU5365296A (en) Human monoclonal antibody against lung carcinoma
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU4752696A (en) Monoclonal antibodies for human osteogenic cell surface antigens
AU2391195A (en) Lymphocyte activation antigens and antibodies thereto
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU5686698A (en) Methods for the production of chicken monoclonal antibodies
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU1423892A (en) Monoclonal antibodies directed towards mycobacterial antigens
EP0977590A4 (en) Human monoclonal antibodies
EP0909278A4 (en) Nephropathy-related immunoglobulin g and antibodies for same
PL320610A1 (en) Fragments of monoclonal antibodies of immunosuppressive activity
AU5688596A (en) Anti-cd14 antibodies for use in the induction of il-10 secre tion
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
AU2828795A (en) Monoclonal antibodies for the reduction of anti-xenogeneic immune responses
AU2170692A (en) Me20: monoclonal antibodies and antigen for human melanoma
AU1809695A (en) Tumor associated monoclonal antibody 123av16